1 / 47

Lipids and Lipoproteins

Lipids and Lipoproteins. Roger L. Bertholf, Ph.D. Associate Professor of Pathology Director of Clinical Chemistry & Toxicology. Classification of lipids. Fatty acids (palmitic, linoleic, etc.) Glycerol esters (triglycerides) Sterols (cholesterol, hormones, vitamin D)

yosef
Download Presentation

Lipids and Lipoproteins

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Lipids and Lipoproteins Roger L. Bertholf, Ph.D. Associate Professor of Pathology Director of Clinical Chemistry & Toxicology

  2. Classification of lipids • Fatty acids (palmitic, linoleic, etc.) • Glycerol esters (triglycerides) • Sterols (cholesterol, hormones, vitamin D) • Terpenes (vitamins A, E, K) • Sphingosine derivatives (sphingomyelin)

  3.   Fatty acids • Even-numbered fatty acids predominate • The most common saturated fatty acids are palmitic (16:0) and stearic (18:0), but unsaturated fatty acids are more common in nature Lauric acid (C12, 12:0, n-dodecanoic acid)

  4. Unsaturated fatty acids • Double bonds in fatty acids are nearly always cis Palmitoleic acid (16:19, 9-hexadecanoic acid)

  5. Essential fatty acids • Mammals can synthesize saturated and mono-unsaturated fatty acids. • Linoleic (18:2) and linolenic (18:3) fatty acids cannot be synthesized, and therefore must be obtained from the diet (plants). • Both are required for the biosynthesis of prostaglandins

  6. Clinical importance of fatty acids • Fecal fatty acids are sometimes measured to detect malabsorptive and pancreatic disorders—the test is mostly considered obsolete • Serum free fatty acids help distinguish between hyperinsulinemic hypoglycemia (FFA normal) and disorders of fatty acid oxidation (FFA elevated and negative ketones)

  7. Glycerol esters (acylglycerols) • Triglycerides are the most abundant family of lipids in plant and animal cells, and are major components of the the human diet Glycerol Triglyceride

  8. Measuring triglycerides (reference method) • Triglycerides are extracted into chloroform prior to analysis Triglycerides fatty acids + glycerol KOH formic acid + formaldehyde Periodate chromogen =570 nm chromotropic acid

  9. Lipase Glycerokinase ATP Glycerol + FFAs Glycerophosphate + ADP Measuring triglycerides (enzymatic method) Triglycerides Glycerophasphate oxidase Dihydroxyacetone + H2O2 Quinoneimine dye max 500 nm Peroxidase

  10. Sterols (cholesterol) • Sterols are steroid backbones that have a hydroxyl group at position 3 and a branched aliphatic chain of 8 or more carbons at position 17

  11. Cholesterol biosynthesis • About 2% (approximately 1 g) of total body cholesterol is replenished each day • Dietary sources account for less than half • Cholesterol is synthesized from Acetyl CoA • 90% of in vivo synthesis occurs in the intestine and liver (although all cells have the capability) • Absorption of dietary cholesterol appears to have a maximum of approximately 1 g/day

  12. “Statin” drugs inhibit this enzyme Cholesterol biosynthesis Acetyl-CoA 3-Hydroxy-3-methylglutaryl-CoA HMG-CoA reductase Squalene Mevalonate Cholesterol + Lecithin Cholesterol ester LCAT

  13. Measuring cholesterol by L-B • The Liebermann-Burchard method is used by the CDC to establish reference materials • Cholesterol esters are hydrolyzed and extracted into hexane prior to the L-B reaction

  14. Cholesteryl ester hydroxylase Cholesterol Cholesterol oxidase Choles-4-en-3-one + H2O2 Phenol 4-aminoantipyrine Peroxidase Quinoneimine dye (max500 nm) Enzymatic cholesterol methods Cholesterol esters • Enzymatic methods are most commonly adapted to automated chemistry analyzers • The reaction is not entirely specific for cholesterol, but interferences in serum are minimal

  15. Lipoproteins • In order to be transported in blood, lipids must combine with water-soluble compounds, such as phospholipids and proteins.

  16. Lipoprotein classes

  17. Appearance of hyperlipidemia • Standing Plasma Test for chylomicrons • Plasma is placed in refrigerator (4°C) overnight • Chylomicrons accumulate as floating “cream” layer • Chylomicrons in fasting plasma are abnormal

  18. Pre-  - + Lipoprotein electrophoresis • LEP is no longer a common laboratory test • Standing plasma test for chylomicrons • Total cholesterol, TG, HDL, and LDL can be measured directly Migration Chylomicrons LDL IDL VLDL Lp(a) HDL

  19. Fredrickson classification

  20. Dextran sulfate HDL, IDL, LDL, VLDL HDL + (IDL, LDL, VLDL) Mg++ Measuring HDL cholesterol • Ultracentrifugation is the most accurate method • HDL has density 1.063 – 1.21 g/mL • Routine methods precipitate apolipoprotein B with a polyanion/divalent cation • Includes VLDL, IDL, Lp(a), LDL, and chylomicrons • Newer automated methods use a modified form of cholesterol esterase, which selectively reacts with HDL cholesterol

  21. Indirect LDL cholesterol • Friedewald formula assumes that all cholesterol is VLDL, LDL, and HDL lipoproteins • Chylomicrons are usually low in normal, fasting subjects, and IDL and Lp(a) are usually insignificant contributors to total cholesterol • Since VLDL is 55% TG and 12% Chol: [LDL Chol] = [Tot Chol] – [HDL Chol] – [TG]/5

  22. Direct LDL cholesterol • Older direct methods for LDL involved precipitation with heparin or polyvinyl sulfate • Newer methods involve precipitation of VLDL, IDL, and HDL with polyvalent antibodies to Apo A and Apo E • LDL is almost exclusively Apo B-100

  23. Direct vs. Indirect LDL • The Friedewald equation assumes that chylomicrons, IDL, and Lp(a) are not significant • Non-fasting specimens can have chylomicrons • TG > 400 mg/dL indicates the presence of chylomicrons (or remnants) • Type III hyperlipidemia is characterized by high -VLDL, which has a 3:1 TG:C ratio

  24. Apolipoproteins • The protein composition differs from one lipoprotein class to another, and the protein constituents are called Apolipoproteins

  25. Functions of apolipoproteins • Activate enzymes involved in lipid metabolism (LCAT, LPL) • Maintain structural integrity of lipid/protein complex • Delivery of lipids to cells via recognition of cell surface receptors

  26. Apolipoprotein content of LPs

  27. A A C,TG C,TG C E B B Chylomicron C,TG E B Cholesterol metabolism (exogeneous) Dietary cholesterol, triglycerides Apo-C, E from HDL Endothelium LPL Hepatocyte B/E receptors Chylomicron remnant

  28. C,TG E B Cholesterol metabolism (endogeneous) Endothelium C,TG LPL C E B VLDL Hepatocyte B-100 receptors C B LDL IDL

  29. Dyslipoproteinemias • Causes can be primary or secondary • Secondary causes include starvation, liver disease, renal failure, diabetes, hypothyroidism, lipodystrophies, drugs • Primary causes of hyperlipidemia: • Increased production • Defective processing • Defective cellular uptake • Inadequate removal

  30. Dyslipoproteinemias • Hyperchylomicronemia • LPL deficiency • Apo C-II deficiency

  31. A A C,TG C,TG C E B B Chylomicron C,TG E B Hyperchylomicronemia Dietary cholesterol, triglycerides Apo-C, E from HDL Endothelium LPL • Chylomicrons • Triglycerides • HDL • LDL Hepatocyte B/E receptors Chylomicron remnant

  32. Dyslipoproteinemias • Hyperchylomicronemia • LPL deficiency • Apo C-II deficiency • Hyperbetalipoproteinemia • Overproduction of VLDL • Enhanced conversion of VLDL to LDL • LDL enriched with cholesteryl esters • Defective LDL structure • Decreased LDL receptors

  33. C,TG E B Hyperbetalipoproteinemia Endothelium C,TG LPL C E B VLDL Hepatocyte B-100 receptors C • LDL Normal TG B LDL IDL

  34. Dyslipoproteinemias • Combined hyperlipoproteinemia • Normal LDL receptors • Overproduction of VLDL and Apo B-100

  35. C,TG E B Combined hyperlipoproteinemia Endothelium C,TG LPL C E B VLDL Hepatocyte B-100 receptors C • LDL Normal TG B LDL IDL

  36. Dyslipoproteinemias • Combined hyperlipoproteinemia • Normal LDL receptors • Overproduction of VLDL and Apo B-100 • Dysbetalipoproteinemia • Both cholesterol and triglyceride elevated • Mutant form of Apo E

  37. A C,TG B Chylomicron Dysbetalipoproteinemia Dietary cholesterol, triglycerides Apo-C, E from HDL A Endothelium C,TG LPL C E B Cholesterol • TG C,TG E B Hepatocyte B/E receptors Chylomicron remnant

  38. Dyslipoproteinemias • Familial hypercholesterolemia • Defect in LDL receptor • Absent • Defective • Incidence = 1:500

  39. C,TG E B Familial hypercholesterolemia Endothelium C,TG LPL C E B VLDL Hepatocyte B-100 receptors C LDL • or n TG HDL B LDL IDL

  40. Dyslipoproteinemias • Familial hypercholesterolemia • Defect in LDL receptor • Absent • Defective • Incidence = 1:500 • Familial defective Apolipoprotein B-100

  41. Familial hypercholesterolemia Endothelium C,TG LPL C E B VLDL Hepatocyte B-100 receptors C C,TG or n LDL E B B LDL IDL

  42. High cholesterol, high LDL • Diet/Lifestyle • 2° to hypothyroidism or nephrotic syndrome (disruption of Apo-B metabolism) • Polygenic: (means we don’t know) • Familial hypercholesterolemia • Familial defective Apo-B • Rare disorders

  43. High TG, normal cholesterol • Diet/Lifestyle • 2° to diabetes, thiazide diuretics, Cs, beta-blockers, CRF/Nephrotic syndrome • Familial hypertriglyceridemia (etiology unknown) • ApoC-III excess (interferes with LPL) • LPL deficiency • ApoC-II deficiency

  44. High cholesterol, TG • Obesity • 2° to steroids, Cs, hypothyroidism, CRF • Familial combined hyperlipidemia (multifactorial) • Peroxisome proliferator-activator receptor • Dysbetalipoproteinemia (Type III) • Hepatic lipase deficiency (rare)

  45. Low cholesterol, low/normal HDL • Abetalipoproteinemia (ApoB degraded after synthesis causes fat malabsorption) • Hypobetalipoproteinemia (genetically defective ApoB) • Chylomicron retention disease (unknown cause)

  46. Low HDL • Lifestyle • 2° to steroids, beta-blockers, progestogens • Familial hypoalphalipoproteinemia (ApoA-I, C-III, or A-IV defects) • ApoA-I variants • Tangier disease (enhanced HDL degredation) • LCAT deficiency

  47. High HDL • Lifestyle (ethanol) • 2° to phenytoin, phenobarbitol, rifampicin (p-450 inducers) and estrogens • Cholesteryl Ester Transfer Protein defects

More Related